Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi.

Umberto Vitolo, Marco Ladetto, Carola Boccomini, Luca Baldini, Federico De Angelis, Alessandra Tucci, Barbara Botto, Annalisa Chiappella, Annalisa Chiarenza, Antonello Pinto, Amalia De Renzo, Francesco Zaja, Claudia Castellino, Alessia Bari, Isabel Alvarez De Celis, Andrea Evangelista, Guido Parvis, Enrica Gamba, Chiara Lobetti-Bodoni, Giovannino CicconeGiuseppe Rossi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi.'. Together they form a unique fingerprint.

Medicine & Life Sciences